Llwytho...
FLT3LG - a biomarker reflecting clinical responses to the immunogenic cell death inducer oxaliplatin
The fms-related tyrosine kinase 3 (FLT3) ligand (FLT3LG) binds to FLT3 on dendritic cells to stimulate their differentiation and expansion, hence facilitating tumor antigen cross-presentation and anticancer immune responses. A recent study by Abrahamsson et al. demonstrates that, in patients receivi...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Oncoimmunology |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Taylor & Francis
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7185211/ https://ncbi.nlm.nih.gov/pubmed/32363127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1755214 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|